Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

Nordic Life Science Insight's Logo
Spago Nanomedical receives approval to initiate the clinical trial SPAGOPIX-01
Medtech

Spago Nanomedical receives approval to initiate the clinical trial SPAGOPIX-01

Spago Nanomedical
February 20, 2019

Spago Nanomedical AB (publ) has received approval from the Swedish Medical Products Agency to initiate the first clinical trial with the contrast agent SpagoPix (SN132D) in patients with breast cancer.

Identify samples by colour to increase productivity
Medtech

Identify samples by colour to increase productivity

Brady
February 11, 2019

The new BradyJet J2000 easily prints reliable, full colour labels for every sample!

Arction Presents: LightningChart® JS
Medtech

Arction Presents: LightningChart® JS

Arction Ltd
January 30, 2019

The time has come – we are happy to announce that LightningChart® is coming for Web! We present LightningChart JS, a lightning-fast charting library for the most demanding JavaScript developers.

ReproUnion has been granted funding for the continuance of the ReproUnion project– we call it ReproUnion 2.0.
Medtech

ReproUnion has been granted funding for the continuance of the ReproUnion project– we call it ReproUnion 2.0.

Medicon Valley Alliance
December 11, 2018

We are happy to be able to announce that ReproUnion has been granted funding for the continuance of the ReproUnion project, which will help establish and further develop the Medicon Valley region as a world-class life science cluster within infertility treatment.

Spago Nanomedical to present at Avanza Börsdag
Medtech

Spago Nanomedical to present at Avanza Börsdag

Spago Nanomedical
October 2, 2018

Spago Nanomedical will participate in Avanza Börsdag, a collaboration between Avanza and Financial Hearings, on Wednesday November 28, 2018.

Mabtech launches revolutionary FluoroSpot & ELISpot reader developed together with R&D partner Qamcom
Medtech

Mabtech launches revolutionary FluoroSpot & ELISpot reader developed together with R&D partner Qamcom

Mabtech
September 27, 2018

Mabtech, a worldwide supplier of kits and reagents for immune monitoring, today unveil a new revolutionary FluoroSpot & ELISpot reader called Mabtech IRIS™ with their R&D partner Qamcom Research and Technology Stockholm, a Technology Application Expert. Mabtech IRIS is a spot reader with precision and accuracy previously not available in the market, creating exciting new possibilities for the research community.

Date
Title
Author
May 15, 2018
Spago Nanomedical receives grant from Vinnova for the development of SpagoPix
Spago Nanomedical
May 2, 2018
New Case Study from NewMindTech!
Arction Ltd
April 26, 2018
Spago Nanomedical participates in EU NANO2ALL project
Spago Nanomedical
April 9, 2018
LightningChart® v.8.3 released
Arction Ltd
April 3, 2018
AbbVie Announces Results from Phase 2 Study Evaluating Rovalpituzumab Tesirine (Rova-T) for Third-Line Treatment of Patients with DLL3-Expressing Relapsed/Refractory Small Cell Lung Cancer
AbbVie
March 1, 2018
Join us at ISHLT 2018 to explore new horizons for optimizing transplantation
XVIVO Perfusion AB
September 6, 2017
Nanologica and Dr Sabrina Valetti receive a research grant of 2.4 million SEK
Nanologica
May 23, 2017
Helping biotech companies through innovative IT solutions
Oslo Cancer Cluster
May 23, 2017
IQoro used in successful joint initiative in care of the elderly
MYoroface

Nordic Life Science - Insight

NLS Insight's goal is to assist the Nordic regions leading innovators in targeting business collaborations, parnership opportunities and investment potential.

info@nlsinsight.com
+47 69 51 02 XX
Olaf Helsets vei 5, 0694 Oslo
Mail iconinfo@nlsinsight.com
Phone Icon+47 69 51 01 94
Adress IconOlaf Helsets vei 5, 0694 Oslo
Facebook icon
Twitter icon
LinkedIn icon
Privacy policy
Subscribe to
our newsletters

Designed by Horn Digital Media 2019